发明授权
- 专利标题： Treatment of complement-associated disorders
- 专利标题（中）： 补体相关疾病的治疗
-
申请号： US11249825申请日： 2005-10-12
-
公开(公告)号： US08007798B2公开(公告)日： 2011-08-30
- 发明人: Avi Ashkenazi , Karim Yussef Helmy , Sherman Fong , Audrey Goddard , Austin L. Gurney , Kenneth James Katschke, Jr. , Menno Van Lookeren , William I. Wood
- 申请人： Avi Ashkenazi , Karim Yussef Helmy , Sherman Fong , Audrey Goddard , Austin L. Gurney , Kenneth James Katschke, Jr. , Menno Van Lookeren , William I. Wood
- 申请人地址： US CA South San Francisco
- 专利权人： Genentech, Inc.
- 当前专利权人： Genentech, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Arnold & Porter LLP
- 代理商 Bonny Yeung; Ginger R. Dreger
- 主分类号： A61K39/395
- IPC分类号： A61K39/395
摘要：
The present invention concerns a recently discovered macrophage specific receptor, CRIg, and its use in the prevention and treatment of complement-associated disorders, including complement-associated eye conditions, such as age-related macular degeneration (AMD) and choroidal neovascularization (CNV).
公开/授权文献
信息查询
